Literature DB >> 20967782

Pathogenesis of CADASIL: transgenic and knock-out mice to probe function and dysfunction of the mutated gene, Notch3, in the cerebrovasculature.

Anne Joutel1.   

Abstract

Small vessel diseases (SVDs) of the brain are the leading cause of vascular cognitive impairment and a major contributor to stroke in the human adult, however, their pathogenesis is poorly understood. Dominant mutations in NOTCH3 cause CADASIL, one of the most prevalent inherited cerebral SVDs. The disease gene encodes a transmembrane receptor primarily expressed in smooth muscle cells of small arteries and pericytes of brain capillaries. Pathogenic mutations alter the number of cysteine residues in the extracellular domain of NOTCH3, leading to its abnormal accumulation in the vessels of patients. Mice lacking NOTCH3 have revealed a critical role for NOTCH3 in the elaboration of small arteries. Despite being incomplete disease models, transgenic mice expressing CADASIL-associated NOTCH3 mutations, have provided important insights into specific aspects of CADASIL pathogenesis, including the functional significance of disease-linked mutations and the earliest pathological events that initiate brain lesions. In this paper, I provide a critical overview of these studies. Moreover, I discuss future directions and further work that needs to be done.
Copyright © 2011 WILEY Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967782     DOI: 10.1002/bies.201000093

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  51 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 2.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?

Authors:  Anne Joutel; Iman Haddad; Julien Ratelade; Mark T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 3.  Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.

Authors:  Eileen M Redmond; Shaunta Guha; Dermot Walls; Paul A Cahill
Journal:  Expert Opin Investig Drugs       Date:  2011-10-18       Impact factor: 6.206

Review 4.  The possible roles of brain pericytes in brain ischemia and stroke.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Junya Kuroda; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-08-10       Impact factor: 5.046

Review 5.  CADASIL: Treatment and Management Options.

Authors:  Anna Bersano; Gloria Bedini; Joshua Oskam; Caterina Mariotti; Franco Taroni; Silvia Baratta; Eugenio Agostino Parati
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

6.  CADASIL mutant NOTCH3(R90C) decreases the viability of HS683 oligodendrocytes via apoptosis.

Authors:  Mibo Tang; Changhe Shi; Bo Song; Jing Yang; Ting Yang; Chengyuan Mao; Yusheng Li; Xinjing Liu; Shuyu Zhang; Hui Wang; Haiyang Luo; Yuming Xu
Journal:  Mol Biol Rep       Date:  2017-06-10       Impact factor: 2.316

Review 7.  Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Anne Joutel; Frank M Faraci
Journal:  Stroke       Date:  2014-02-06       Impact factor: 7.914

8.  Novel pathological features and potential therapeutic approaches for CADASIL: insights obtained from a mouse model of CADASIL.

Authors:  Xiao-Yun Liu; Maria E Gonzalez-Toledo; Austin Fagan; Wei-Ming Duan; Yanying Liu; Siyuan Zhang; Bin Li; Chun-Shu Piao; Lila Nelson; Li-Ru Zhao
Journal:  Ther Targets Neurol Dis       Date:  2014-12-02

Review 9.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 10.  Smooth muscle cell phenotypic switching in stroke.

Authors:  Marine Poittevin; Pierre Lozeron; Rose Hilal; Bernard I Levy; Tatiana Merkulova-Rainon; Nathalie Kubis
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.